UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000044097 |
|---|---|
| Receipt number | R000050357 |
| Scientific Title | Bacteremia in diabetic ketoacidosis patients: a retrospective cohort study |
| Date of disclosure of the study information | 2021/05/03 |
| Last modified on | 2023/01/21 23:58:13 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Bacteremia in diabetic ketoacidosis patients: a retrospective cohort study
Acronym
Bacteremia in diabetic ketoacidosis patients
Scientific Title
Bacteremia in diabetic ketoacidosis patients: a retrospective cohort study
Scientific Title:Acronym
Bacteremia in diabetic ketoacidosis patients
Region
| Japan |
Condition
Condition
diabetes ketoacidosis
Classification by specialty
| Medicine in general |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
Study aimed to determine the rate of
bacteremia in patients with diabetic ketoacidosis (DKA).
Basic objectives2
Others
Basic objectives -Others
To investigate the factors associated with the positive blood culture.
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
the rate of bacteremia
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 18 | years-old | <= |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
Patients aged more than and equal to 18
years who visited emergency department in Akashi medical center with a diagnosis of DKA and HHS between Jan 1, 2008 and December 31, 2020
Key exclusion criteria
Those without demographic data, evidence of ketosis, plasma glucose, bicarbonate, pH or plasma osmolarity.
Target sample size
100
Research contact person
Name of lead principal investigator
| 1st name | Naoto |
| Middle name | |
| Last name | Ishimaru |
Organization
Akashi Medical Center
Division name
Department of General Internal Medicine
Zip code
6740063
Address
Akashi
TEL
0789361101
maru-tkb@umin.ac.jp
Public contact
Name of contact person
| 1st name | Naoto |
| Middle name | |
| Last name | Ishimaru |
Organization
Akashi Medical Center
Division name
Department of General Internal Medicine
Zip code
6740063
Address
743-33 Yagi, Ohkubo-cho, Akashi, Hyogo 674-0063, Japan
TEL
0789361101
Homepage URL
maru-tkb@umin.ac.jp
Sponsor or person
Institute
Akashi Medical Center
Institute
Department
Personal name
Funding Source
Organization
None
Organization
Division
Category of Funding Organization
Other
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Akashi Medical Center
Address
743-33 Yagi, Ohkubo-cho, Akashi, Hyogo 674-0063, Japan
Tel
0789361101
yokoyama.naoki@aijinkai-group.com
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2021 | Year | 05 | Month | 03 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2021 | Year | 05 | Month | 03 | Day |
Date of IRB
| 2021 | Year | 05 | Month | 06 | Day |
Anticipated trial start date
| 2021 | Year | 05 | Month | 06 | Day |
Last follow-up date
| 2021 | Year | 06 | Month | 30 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Demographic data, the presence of bacteremia, blood pressure, pH, plasma glucose, bicarbonate level and plasma osmolarity were obtained from patient's charts.
Management information
Registered date
| 2021 | Year | 05 | Month | 03 | Day |
Last modified on
| 2023 | Year | 01 | Month | 21 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050357
